Am J Otolaryngol Head Neck Surg | Volume 6, Issue 5 | Review Article | Open Access

Thyroid Hurthle Cell Neoplasms: Review Article

Abdulhaleem M^1* and Aldajani A^2,3

¹Department of Otolaryngology Head and Neck Surgery, Intermed Clinic, Jeddah, Saudi Arabia ²Department of Otolaryngology Head and Neck Surgery, Collage of Medicine, University of Jeddah, Jeddah, Saudi
Arabia
³Department of Otolaryngology Head and Neck Surgery, McGill University Health Center, Canada

^*Correspondance to: Abdulhaleem M, 

Fulltext PDF

Abstract

Hurthle cell carcinoma is a rare type of Differentiated Thyroid Cancer (DTC), accounting for only 5% of all cases of DTC [1]. In 2017, the World Health Organization reclassified the Hurthle cell variant of follicular thyroid carcinoma as a distinct type, due to its different histopathological characteristics from follicular thyroid carcinoma. This reclassification was supported by recent discoveries in molecular characteristics through genetic sequencing tests. Despite these advances, the behavior of Hurthle cell carcinoma and adenoma remains unpredictable. In this paper, we present a short literature review of Hurthle cell neoplasms.

Keywords:

Hurthle cell carcinoma; Hurthle cell neoplasms; Hurthle cell adenoma; Follicular carcinoma

Citation:

Abdulhaleem M, Aldajani A. Thyroid Hurthle Cell Neoplasms: Review Article. Am J Otolaryngol Head Neck Surg. 2023; 6(5): 1243..